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Abstract
Foreign body reaction (FBR), initiated by adherence of macrophages to biomaterials, is associated with several
complications. Searching for mechanisms potentially useful to overcome these complications, we have established the
signaling role of monocytes/macrophages in the development of FBR and the presence of CD34
+ cells that potentially
differentiate into myofibroblasts. Therefore, CD68
+ cells were in vitro activated with fibrinogen and also purified from the
FBR after 3 days of implantation in rats. Gene expression profiles showed a switch from monocytes and macrophages
attracted by fibrinogen to activated macrophages and eventually wound-healing macrophages. The immature FBR also
contained a subpopulation of CD34
+ cells, which could be differentiated into myofibroblasts. This study showed that
macrophages are the clear driving force of FBR, dependent on milieu, and myofibroblast deposition and differentiation.
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Introduction
Implanted biomaterials, usually physically and chemically
stable, non-immunogenic and non-toxic, trigger an innate immune
response. This foreign body reaction (FBR) is associated with
several complications for implanted medical devices [1–3]. FBR is
initiated by the adhesion and denaturation of fibrinogen (FG) [4]
exposing P1 and P2 epitopes recognized by Mac-1 integrin of
phagocytes (neutrophils and macrophages) [5]. Degradable
implant materials are removed by macrophages, while non-
degradable implant materials will be encapsulated [6]. This FBR
capsule comprises 1 internal layer of macrophages, several layers
of (myo)fibroblasts and, in the case of intraperitoneal implantation,
an external layer of mesothelial cells [7]. However, to do so the
macrophage should alter its classical phagocytic action, hypothet-
ically to more wound healing phenotype, thereby providing the
following functions: inhibition of pro-inflammatory cytokine
production, promotion of extracellular matrix deposition, attrac-
tion of other immune cells.
Recently, we showed attraction of different types of primitive
cells, possessing colony forming capacity and differentiation
potential towards the adipo-, osteo- and myofibroblast lineages,
during the immature stages of the FBR [8]. These cells might
therefore be the progenitors of FBR’s (myo)fibroblast population.
Yet, macrophages remain present during the different stages of
FBR [8] and might also transdifferentiate into myofibroblasts [9–
11]. Furthermore, it has been found that fibrocytes, a specific
macrophage-derived population, contribute to wound healing and
other myofibroblast tissue formations [12–16]. Nevertheless, too
little is known about the signaling mechanisms of macrophages in
the FBR which could be involved in attracting the primitive cells.
This study profiles gene expression of in vitro fibrinogen (FG)
activated monocytes/macrophages as well as that of freshly
isolated CD68
+ cells from 3-days implants, against a background
of unactivated monocytes/macrophages. We aimed at distinguish-
ing between 3 major responses. The first or adhesion response is
the altered gene expression induced by binding of denatured
fibrinogen solely. The FBR response appears when the monocyte/
macrophage is in its natural FBR environment in vivo. Finally, the
adhesion in FBR response defined as the overlap between both the
adhesion and FBR response.
Another aim was to functionally examine the isolated CD68
+
and CD34
+ populations and assess their myofibroblast differen-
tiation potential. This was all done at the very early stage of FBR,
well before the in vivo appearance of myofibroblast markers in this
tissue, but at a stage where recruitment and signaling seem to be
crucial [8].
Materials and Methods
Animals and ethics statement
Male Wistar rats (380–400g) were selected, for gene expression
(n=27) and in vitro cell studies (n=24), and cared for in
accordance with the ‘‘Guide for the Care and Use of Laboratory
Animals’’ (NIH publication 85-23, revised 1985). The study was
approved by the ethics committee for animal experiments of the
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(P043/2008).
Surgery
Anaesthesia was induced with 4% isoflurane in 100% oxygen
delivered at 1 l/min for 5 min and maintained with 2% isoflurane
in 100% oxygen delivered at 0.5 l/min during the surgical
procedure taking approximately 20 min. After shaving and
disinfecting the abdomen, a pararectal incision of approximately
1.5 cm was made through the skin, abdominal muscles and
peritoneum. Acellular photo-oxidized bovine pericardium patches
(1.3 cm
2) (Cardiofix
TM, Sulzer Carbomedics, Austin, Texas,
USA), suspended in stainless steel cages, were inserted into the
peritoneal cavity and fixed to the abdominal wall with transab-
dominal sutures.
Cell isolation
After 3 days in the peritoneal cavity, deposited neotissue was
harvested from the retrieved patches and incubated in a 0.2%
collagenase A (Roche Diagnostics, Indianapolis, USA)/0.3%
plasmin (Sigma-Aldrich, Bornem, Belgium) solution for 30 min
at 37uC. The suspension was then poured over a 100 mm and
40 mm cell strainer (BD Biosciences, Erembodegem, Belgium) and
the red blood cells (RBC) were lysed with 10 ml 100 mM NH4Cl
(Sigma-Aldrich). Subsequent steps were performed at 4uC. The
cells were washed with PBS and labeled with a biotinylated CD68
(clone ED1; Serotec, Oxford, UK) or CD34 antibody (Clone
QBEnd 10; Dako, Heverlee, Belgium) and subsequently with anti-
biotin or anti-mouse paramagnetic microbeads (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany), respectively. The cell
suspension was applied onto a MACS separation column (Miltenyi
Biotec) and the CD68
+ or CD34
+ cells were again poured over a
new MACS separation column to enhance specific selection.
Subsequently, from the CD34
2 cell fraction, the CD68
+ cells were
collected. Immediately after isolation of CD68
+ cells, the cells were
exposed to polystyrene SPHERO Fluorescent Yellow Particles of
0.87 mm (Spherotech Inc., IL, USA) at a concentration of 20
beads/cell for 1 hour at 37uC in a volume of 100 ml PBS.
Phagocytosis of the beads was confirmed by an Axiocam MRc5
camera (Zeiss).
Cell culture
CD68
+,a sw e l la sC D 3 4
+,C D 3 4
2CD68
+ and CD34
2CD68
2
cells isolated from 3-days implants were cultured in Mesencult
medium containing 20% mesenchymal stem cell stimulatory
supplements (StemCell Technologies, Vancouver, Canada) and 1%
antibiotics (Invitrogen, Merelbeke, Belgium). Cultures (10
5 cells/cm
2)
were performed in 8-chamber polystyrene vessels (BD Biosciences)
for 1–3 weeks.
In vitro activation
Heparinized blood, collected by cardial punction from anaesthe-
tized rats, was suspended in 1 volume PBS (pH 7.4, Invitrogen),
applied onto the same volume of Histopaque 1077 (Sigma-Aldrich)
and centrifuged (7506g) for 30 min. Mononuclear cells were
collected and washed with PBS. RBCs were lysed and CD68
+ cells
purified as aforementioned. Selected cells were resuspended in
RPMI 1640 culture medium (Sigma-Aldrich), with 2 mM L-
glutamine (Invitrogen), 1% antibiotics or antimycotic solution
(Invitrogen) and 10% foetal bovine serum (Invitrogen), and seeded
at a concentration of 200.000 cells/well onto PTFE (Gore-TexH
Vascular Graft, Gore, Flagstaff, Arizona) coated with FG (10 mg/ml)
(Labconsult NV, Brussels, Belgium) in a 24 well plate and cultured
for 3 days. The optimal coating concentration (data not shown) was
validated by ELISA with an anti-fibrinogen antibody (Gentaur,
Brussels, Belgium). Monocytes/macrophages purified from blood by
the aforementioned CD68
+ selection, without in vitro incubation,
served as controls.
Gene expression
Total RNA was isolated from FG-activated, FBR and blood
CD68
+ cells using Trizol (Invitrogen) and RNeasy Mini RNA
isolation columns (Qiagen, Hilden, Germany).
For microarray processing, in vitro activated, FBR and blood
CD68
+ cells were analyzed in triplicate on Rat Genome 230 2.0
Array GeneChips (Affymetrix, High Wycombe, UK) by a
specialized microarray facility (DNAVision, Gosselies, Belgium)
according to the manufacturer’s double-round T7-based amplifi-
cation protocol (Affymetrix). The data discussed in this publication
have been deposited in NCBI’s Gene Expression Omnibus [17]
and are accessible through GEO Series accession number
GSE21682 (GSM540894-GSM540902) (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE21682).
The Microarray Suite Statistical Algorithm (MAS5.0, Affyme-
trix) was applied for analysis. For comparison analysis, the
contrasts were computed with the Robust Multichip Analysis
(RMA) algorithm using the R statistical language [18]. Gene
expression data were visualized in the context of specific biological
and functional pathways using Gene Map Annotator and Pathway
Profiler (GenMAPP, http://genmapp.org). The contribution of
overexpressed genes (p,0.001) in the different pairwise compar-
isons was investigated with GenMAPP 2.1 (www.genmapp.org) in
31 out of 149 available pathway MAPPs (www.wikipathways.org)
(May 2010) [19], related to signaling and immune response
(Table 1). For gene expression validation, 2 PCR primer pairs
(Table 2) for each of the six comparisons were designed using
Primer3 shareware (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi). RT-PCR of a standardized quantity (30 ng)
of total RNA (n=6/group) was performed as already published by
our group [20]. Glyceraldehyde 3-phosphate dehydrogenase
(Gapdh) gene expression was used as positive control and for
normalization. 5 ml of the Gapdh PCR product and 5 mlo f
Mmp14 PCR product (as for the other PCR products) were
mixed. One ml of each mix was analyzed using the DNA 1000 Kit
with the 2100 Bioanalyzer (Agilent Technologies). Simultaneous
loading allowed assessment of the genes, as already described [20].
Immunohistochemistry
Prior to staining, cell cultures were fixed in ice-cold acetone for
10 minutes. Following primary antibodies were used: TGF-b
receptor type II (TGF-bRII) (clone E-6; Santa Cruz Biotechnol-
ogy, Santa Cruz, USA), FITC-conjugated CD34 (clone QBEnd
10; Dako), CD68 (clone ED1; Serotec), alpha smooth muscle actin
(ASMA) (clone 1A4; Dako), desmin (clone D33; Serotec) and
smoothelin (polyclonal; Santa Cruz Biotechnology). TGF-bRII
was visualized using an Envision kit (Dako) with a horse-raddish
peroxidase labeled anti-mouse antibody and amino-ethyl-carba-
zole as substrate. All other antibodies, except for CD34, were
detected with FITC-conjugated secondary antibodies.
Simultaneous staining without primary antibodies excluded
false positive results. To avoid false positive results in the ASMA
staining on the freshly isolated CD68
+ cell spots and as the mouse
monoclonal CD68 antibody was already attached to the cells,
these were blocked with goat anti-mouse/biotin (GAM/B) for 5 h
prior to the actual staining procedure.
To detect the myofibroblast differentiation, double staining was
performed after 21 days of culturing for ASMA combined with
Function of CD68+ Cells in FBR
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biotinylated rabbit anti-mouse secondary antibody (Dako) and
streptavidin/texas red (Perkin Elmer, Waltham, USA), the second
primary antibody was added and stained with a FITC-conjugated
secondary antibody (Dako). Double staining for ASMA and CD68
was performed accordingly. The ASMA-CD34 double staining
was executed by applying ASMA using streptavidin/texas-red and
subsequent overnight staining with the CD34/FITC-conjugated
primary antibody. Cell nuclei were visualized with Vectashield
DAPI-containing mounting medium (Vector Laboratories, Bur-
lingame, USA). For cell phenotyping, 500 cells in total were
evaluated in each sample, as described before [21].
Statistical analysis
Because of the confined observations, non-parametric statistics
were used (SPSS 15, SPSS Inc., Chicago, IL, USA). Comparison
betweenmorethantwogroups wasperformed witha Kruskal-Wallis
test. If significance (p,0.05) was observed, pairwise comparisons of
the groups were performed with non-paired Wilcoxon-Mann-
Whitney tests. These were considered significant if p,0.05.
Results
General gene expression
Overall, more transcripts were present in in vitro activated and
FBR CD68
+ cells (47.1% and 45% from a total of 31099 probe
sets) as compared to freshly isolated CD68
+ cells (40.4%). Most
probe sets were present (35.2%) in all samples. The distribution of
gene expression comparisons (p,0.001) are summarized in a
Venn-diagram (Fig. 1). The figure also clearly shows the 3 distinct
groups of genes subjected to further analysis. The 54 genes
overexpressed by FG-activated monocytes/macrophages com-
pared to circulating and FBR monocytes/macrophages were
considered as the adhesion response of monocytes/macrophages
induced by FG activation solely. The 197 genes overexpressed by
FBR CD68
+ cells compared to the other 2 conditions represent a
FBR CD68
+ cell response, dependent on the environment. The
overlap between both (104 genes) is considered FG adhesion
within FBR specific genes. All upregulated genes of these 3 groups
(with their associated log base 2 fold changes (logFC)) are available
in supplemental tables S1, S2, and S3.
Table 1. Examined GenMAPP pathways.
GenMAPP pathway Genes overexpressed by FBR monocytes/macrophages
Alpha6-Beta4-Integrin Signaling Pathway Cdkn1a
Apoptosis Mechanisms Jun, Nfkbib, RGD:727889, Tnf
Apoptosis Modulation by HSP70 Hspa1a
B Cell Receptor Signaling Pathway Atf2, Gab1, Jun, Rela
Complement Activation, Classical Pathway /
Cytokines and Inflammatory Response (Biocarta) Csf2, Csf3, IL-1a, IL-1b, IL-6, IL-10, Tnf
G Protein Signaling Pathways Akap7, Slc9a1
IL-1 Signaling Pathway IL-1a, IL-1b, IL-1r2, Irak2, Nfkbib, Rela
IL-2 Signaling Pathway Icam1, Rela, Socs3
IL-3 Signaling Pathway Atf2, Gab1, Socs3
IL-4 Signaling Pathway Atf2, Dok2, IL-4ra, Rela, Socs3
IL-5 Signaling Pathway Atf2, Icam1, Jun
IL-6 Signaling Pathway Gab1, IL-6, Jun, Socs3
IL-7 Signaling Pathway /
IL-9 Signaling Pathway Socs3
Inflammatory Response Pathway IL-4ra
Integrin-mediated Cell Adhesion Itga5, Itgav, Mapk6
Kit Receptor Signaling Pathway /
Matrix Metalloproteinases Mmp13, Tnf
Monoamine GPCRs /
Nuclear Receptors /
Oxidative Stress Mt1x
Peptide GPCRs /
Signal Transduction of S1P Receptor Mapk6
Signaling of Hepatocyte Growth Factor Receptor Jun
Small Ligand GPCRs Ptger2
T Cell Receptor Signaling Pathway Jun
TGF Beta Receptor Signaling Pathway Atf2, Cav1, Cdc27, Cdkn1a, Fosb, Jun, Tgif1
TGF Beta Signaling Pathway Eng, Jun, Tgif1, Tnf
TNF-alpha-NF-kB Signaling Pathway Cav1, Gab1, Nfkb2, Nfkbib, Nfkbiz, Tnf, Tnip1, Rela
Toll-like receptor signaling pathway Cd14, Ccl4, Cxcl10, IL-1b, IL-6, Jun, Rela, Tnf
doi:10.1371/journal.pone.0012949.t001
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Upregulated genes were found in 8 examined pathways.
Epidermal growth factor receptor (EGFR) was upregulated during
the primary response in the a6-b4 integrin signaling pathway of
genMAPP. Whereas transforming growth factor b receptor 1
(TGF-bR1) was overexpressed in the TGF-b signaling pathway
(Fig. 2A) and was together with cyclin E (Ccne1) present in the
TGF-b receptor signaling pathway. FG binding of CD68
+ cells
induced upregulation of both Ccne1 and cyclin D2 (Ccnd2) in the
B cell receptor signaling and only of Ccnd2 in IL-7 signaling
pathway. Furthermore, somatic cytochrome c (Cycs), part of the
apoptosis (apoptosis mechanisms and apoptosis modulation by
HSP70) and the B-cell receptor signaling pathways, was
overexpressed by in vitro activated CD68
+ cells. Lastly, Ras
protein activator like 2 (Rasal2) was apparent in the TNFa/NF-kb
signaling pathway.
FBR gene response
All the genes exclusively overexpressed by FBR CD68
+ cells in
the 31 examined pathways are listed in table 1. This population
showed upregulated expression of several cytokines and inflam-
matory response genes (Fig. 2B), clustered around the macro-
phages. These macrophages signal to T helper cells by tumor
necrosis factor a (TNFa) and several interleukines (IL-1a, IL-1b,
IL-6 and IL-10). These factors were also apparent in the signaling
to neutrophils, fibroblasts, endothelial cells, hematopoietic stem
cells and in the induction of fever. Amongst 197 genes
overexpressed by these FBR monocytes/macrophages, several
receptors such as intercellular adhesion molecule 1 (ICAM-1),
integrin a5 (Itga5), integrin aV (ItgaV), vascular cell adhesion
molecule 1 (VCAM-1), syndecan 4 (Sdc4), interleukin 4 receptor a
(IL-4ra), CD14 antigen (CD14), endothelial cell adhesion
molecule (Esam) were present. Matrix metalloproteinase 13
(Mmp13) was also present in this response.
Gene response FG adhesion in FBR
FG adhesion of monocytes/macrophages during the FBR
induced overexpression of disabled homolog 2 (Dab2) and
activating transcription factor 3 (Atf3), which were present in the
TGF-b receptor signaling pathway. While in IL-2, IL-3 and IL-6
signaling pathways, respectively phosphatidylinositol 3-kinase
catalytic beta polypeptide (Pik3cb), solute carrier family 2 member
1 (Slc2a1) and serum/glucocorticoid regulated kinase (Sgk) were
Table 2. Selected primers for PCR analysis.
Primer Abbreviation Comparison Sequence Product size (bp)
Glyceraldehyde 3-phosphate dehydrogenase Gapdh Housekeeping gene L: AAACCCATCACCATCTTCCA
R: GTGGTTCACACCCATCACAA
198
Matrix metallopeptidase 14 Mmp14 Cu - IVo L: TACCCACACACAACGCTCAC
R: TCCCAAACTTATCTGGAACACC
149
Tetraspanin 5 Tspan5 Cu - IVo L: GGGTGTTGGCATTTGTTTTC
R: GGCTTGCATTGGAGTCTGTG
204
Lysosomal-associated membrane protein 3 Lamp3 Co - IVu
Co - FBRu
L:AGCAGAGCATCCAGCTATCA
R:ACCCACAACACAGAGGACAA
170
Neuropeptide Y NpY Co - IVu L: ACTACTCCGCTCTGCGACAC
R: CAACGACAACAAGGGAAATG
291
Ceruloplasmin Cp Cu - FBRo L: CACAGATGGCACCTTTACGA
R: CAGTTTGTCATCGGCTCTTTG
223
Cathepsin L Ctsl Cu - FBRo L: CAGCCTTAGCCACTCCAAAA
R:CTTCTCCCACACTGCTCTCC
122
Interleukin 16 IL16 Co - FBRu L: CAGCGAGCCTCAGAAGAAAC
R: TCTTCCTGTAGCAGCAGTGG
117
Chemokine (C-C motif) ligand 24 Ccl24 IVu - FBRo L: GTGACCATCCCCTCATCTTG
R: TGCTATTGCCTCGGAGTTTC
271
Vascular cell adhesion molecule 1 Vcam1 IVu - FBRo L: GAACCCAAACAAAGGCAGAG
R: TTAGCTGTCTGCTCCACAGG
169
Interleukin 18 binding protein IL18bp IVo - FBRu L: GTCTCCAGCAGTCCCAACTAA
R: CATTGCCCAGCCAGTAGAG
146
Transmembrane protein 97 Tmem97 IVo - FBRu L: CTGGGCCTCTACTTCGTCTC
R: TGTGAACCGCATAGATGATTG
280
Table indicating the different primers used for the PCR analysis. C=control monocytes/macrophages; IV=in vitro activated monocytes/macrophages; FBR=monocytes/
macrophages derived from FBR; L=left primer; R=right primer; bp=base pairs.
doi:10.1371/journal.pone.0012949.t002
Figure 1. Upregulated genes. Venn-diagram showing the genetic
overlap between the pairwise comparisons of in vitro activated, blood
and FBR monocytes/macrophages (p,0.001).
doi:10.1371/journal.pone.0012949.g001
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and a6-b4 integrin signaling pathways. Sprouty-related EVH1
domain containing 2 (Spred2) part of the kit receptor pathway and
tissue inhibitor of metallopeptidase 1 (Timp1) in the matrix
metalloproteinases’ pathway were also upregulated by this cell
population. Lastly heme oxygenase 1 (Hmox1) was present in the
oxidative stress pathway.
PCR gene expression verification
The differential expression between the 3 groups of monocytes/
macrophages (circulating, in vitro activated and FBR CD68
+ cells)
was technically verified by selecting 2 genes of the 10 most
differentially expressed transcripts in each comparison. Reverse
transcriptase-PCR results are depicted in figure 3. All the PCR
products were of expected sizes and significantly confirmed the
differential expression in each comparison.
FBR cell differentiation
CD68, CD34 and ASMA expression of freshly isolated FBR
CD68
+ cells compared to that of 1 week and 3 weeks cultures is
summarized in figure 4. 93.662.7% of the cells isolated showed to
be positive for the CD68 antigen, whereas 8.266.6% of these
freshly isolated cells were CD34
+ and no ASMA
+ cells were
present. Double staining of CD34 and CD68 was also observed
(data not shown). After 1 week of culture, the CD68 and CD34
surface marker expression was comparable to that of the freshly
isolated CD68
+ cell population from the FBR. ASMA
+ cells
(10.9613.3%) could be detected, but with high variability. Only
after 3 weeks of culture, the cell population showed a significant
increase in CD34 expression to the level of 28.9611.2%
(p=0.009). ASMA expression was now significantly increased to
the level of 24.7625.2% (p=0.015), but its high variability was
maintained.
The phagocytic activity of the isolated monocyte/macrophage
population (CD68
+) was confirmed by uptake of particles (Fig. 5A
and supplementary Video S1). The double staining of CD68
+ cells
cultured for 3 weeks showed the presence of vimentin, ASMA and
a minimal expression of smoothelin and desmin. In figure 5B, the
expression of ASMA (red) and smoothelin (green) can be observed.
To verify possible transdifferentiation of ASMA
+ cells from the
CD68
+ cell population, 21-days cultures were also double stained
for ASMA and CD68. No CD68
+ASMA
+ cells could be observed
(Fig. 5C). Yet CD68
+ cells, that had engulfed fluorescent particles,
showed ASMA expression and myofibroblast morphology with a
polygonal cell shape and cell-to-cell connections after 3 weeks of
culture (Fig. 5D).
In cells cultured for 21 days, no CD34 staining at membrane
level could be observed. However, specifically in the ASMA
+ cells,
an intracytoplasmic CD34 staining was found (Fig. 5E). Also the
CD34
+ cell fraction showed 54.1635.2% of ASMA
+ cells whereas
the CD34
2CD68
+ and CD34
2CD68
2 cell fractions showed
20.466.0% and 81.9618.1% ASMA
+ cells, respectively, which
was a significant difference (p=0.008). Additionally, the total
CD34
+ cell fraction, isolated from 3-days implants, showed
fibrocyte-like cells after 5 days of cultivation, but no ASMA
+ cells
could be detected after 3 weeks of culture.
The possibility of autocrine stimulation with TGF-b, of which
some mediators were present in the FG adhesion, FG adhesion in
FBR and FBR gene responses, was also examined by determining
the expression of the TGF-bRII in CD68
+ cell cultures. As can be
Figure 2. GenMAPP pathways. Upregulated genes present in GenMAPP pathways of ‘‘TGF-B signaling pathway’’ (A) and ‘‘cytokines and
inflammatory response’’ (B).
doi:10.1371/journal.pone.0012949.g002
Figure 3. Technical verification of microarray results by RT-PCR.
Overexpressed (black) and underexpressed (grey) genes are schematically
represented for the 3 pairwise comparisons (A: C – IV; B: C – FBR; C: IV –
FBR) by applying the ‘‘differential expression index’’: (X2Y)/(X+Y) with
X=mean (triplicates gene 1 in tissue type 1) and Y=mean (triplicates
gene 1 in tissue type 2). Standard deviations were calculated for this
differential expression index. C=control monocytes/macrophages; IV=in
vitro activated monocytes/macrophages; FBR=monocytes/macrophages
derived from FBR. The full gene names can be found in table 2.
doi:10.1371/journal.pone.0012949.g003
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+, CD34
+ and ASMA
+ cells within the freshly
isolated CD68
+ cell population from the FBR as well as at 1 week and 3 weeks culturing of this CD68
+ cell population. Bars represent mean; errors
represent standard deviation. * significant difference from freshly isolated CD68
+ cell population (FBR). # significant difference from FBR CD68
+ cells
cultured during 3 weeks.
doi:10.1371/journal.pone.0012949.g004
Figure 5. Isolation and differentiation of CD68
+ cells. (A) Cellular phagocytosis of yellow/green fluorescent particles by the purified CD68
+ cell
population from FBR. (B) ASMA (red) and smoothelin (green) expression in FBR CD68
+ cells cultured for 21 days in complete Mesencult medium. (C)
ASMA (red) and CD68 (green) expression of isolated cells cultured for 21 days in complete Mesencult medium. Small CD68
+ cells and larger ASMA
+
cells can be observed. (D) Functional macrophages that have engulfed yellow fluorescent particles show an expression of ASMA (red) as well as a
morphological myofibroblast aspect. (E) Double staining for ASMA (red) and CD34 (green). The presence of intracytoplasmic CD34 expression can be
clearly seen (white arrow). (F) Picture showing TGF-b receptor type II staining of a 42 days old CD68+ cell culture. TGF-b receptor type II staining
appears in red-brown and nuclei appear in blue. The objective lenses used are Plan-APOCHROMAT 1006/1.4 (A, D, E) and Plan-APOCHROMAT 206/
1.4 (B, C, F).
doi:10.1371/journal.pone.0012949.g005
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was found in nearly all cultured cells, with stronger expression in
the small round cells present.
Discussion
With this study, we primarily aimed at understanding the
functions of monocytes/macrophages in the early stages of FBR.
This by studying specific gene expression profiles related to FG
induced adhesion, FBR in general and FG induced adhesion of
FBR monocytes/macrophages. Additionally, we have also studied
the myofibroblast differentiation potential of different cell
phenotypes involved in FBR.
Comparison of blood and in vitro activated monocytes/
macrophages allowed identification of the primary pathways
initiated by the recognition of the P1 and P2 epitope of FG. Within
this adhesion response, genes were upregulated that are involved
in cell adhesion (EGFR, TGF-bR1), apoptosis (Cycs), cell cycle
and intracellular signaling (Ccne1, Ccnd2, Rasal2). According to
the classification of macrophages into classically activated, wound-
healing and regulatory macrophages, this response only showed
characteristics of classically activated macrophages [22]. FG
induced the upregulation of Rasal2 in the TNFa signaling
pathway, which suggests already the onset of TNFa (pro-
inflammatory) excretion by macrophages, which is confirmed by
the expression profile of FBR CD68
+ cells. It was already
described that FG induces a pro-inflammatory response, which
eventually results in the production of TGF-b [23]. This is
confirmed by our study as TGF-bR1 and even TGF-b1 (p=0.01)
was upregulated in the in vitro activated monocytes/macrophages.
The importance of TGF-b signaling was also apparent in the gene
expression of FBR CD68
+ cells (Fig. 2B) and even in the cell
culture study (Fig. 5F).
The FBR response elucidated additional upregulation of
pathways when a full FBR is induced, excluding the genes related
to monocyte/macrophage specific FG adhesion analyzed sepa-
rately, but including the attraction of other cells [8]. GenMAPP
analysis showed the relevance of pathways related to cytokine
release, (innate) immune response (IL-1a, IL-1b, IL-6, IL-10 and
TNFa), cell adhesion (such as Icam-1, Vcam-1,…) and matrix
remodeling (Mmp13). This response mainly showed properties of
classically activated macrophages (IL-1b, IL-6, TNF, Ccl20,
Cxcl10), but also of wound-healing (Factor XIII-A) and regulatory
macrophages (IL-10) [22,24]. The TGF-b production by classi-
cally activated macrophages in response to fibrinogen stimulation,
can promote the alternative activation of macrophages initiated by
IL-13 [23]. In this study, monocytes/macrophages of the FBR
showed overexpression of IL-13 receptor alpha 1 (p=0.004) and
IL-4 receptor alpha. This was not the case in the in vitro activated
CD68
+ cells and clearly confirms the necessary interaction with
the cells environment described before [22]. Moreover these FBR
monocytes/macrophages showed overexpression of arginase 1
(Arg1) (p=0.002), which can be initiated by the TH2 cytokines IL-
4 or IL-13 and even by TGF-b or GM-CSF [25]. Arg 1 is an
important enzyme in the fibroblast proliferation and in the
synthesis of collagen by fibroblasts [23] and diminishes the
inflammatory NO production, a function of classically activated
macrophages [26].
Further analysis revealed the response of FBR monocytes/
macrophages specific after binding with FG and again showed the
importance of TGF-b signaling during the early FBR, as several
TGF-b inducible genes (Dab2, Atf3, Timp1 and Sgk) were
upregulated [27–30]. Heme oxygenase 1 induces the alternate
activation of classically activated macrophages and confirmed the
progressive switch from the pro-inflammatory to anti-inflamma-
tory effects of macrophages during the early FBR [31].
During the FBR, primitive cells were attracted and shown to
differentiate into myofibroblasts, the main cell population of
mature FBR-tissue [8]. However, it has been shown that
macrophages from FBR-tissue possess myofibroblast differentia-
tion potential [9–11], yet they are potentially confounded with
fibrocytes. Fibrocytes, of myeloid origin [32], express hematopoi-
etic markers such as CD34, CD45 and monocyte/macrophage
markers, and are known to express ASMA, vimentin and collagen
upon TGF-b stimulation [15,33].
A small fraction of the isolated cells (<8%) expressed CD34 and
might be fibrocytes, especially because signs of myofibroblast
differentiation were absent. When cultured, these cells gradually
expressed ASMA, as well as vimentin, smoothelin and desmin.
Selective proliferation and differentiation of these cells within the
CD68
+ cell population was indicated by the decreased CD68 and
increased CD34 expression during culturing.
Remarkable, there were 2 distinct populations of cells observed
after 3 weeks, consisting of small, round, CD68
+CD34
2ASMA
2
cells, together with very large, polygonal shaped cells being
CD68
2CD34
+ASMA
+. In the ASMA
+ cells, an intracytoplasmic
CD34 staining could be observed, while there was no CD34
staining in the ASMA
2 cells. Internalization of the CD34 receptor
has already been shown to exist by receptor-mediated endocytosis
[34]. This intracytoplasmic CD34 staining in ASMA
+ cells shows
that these myofibroblast-like cells originate from the CD34
+
subpopulation within the CD68
+ cell population. This supports the
fact that the CD34
+CD68
+ cell population is important for
myofibroblast differentiation of the cultures. This cell population
could also be mistaken for myeloid precursors of macrophages. So
alternatively, these monocytes/macrophages attract macrophage
precursors expressing C-fms and make them differentiate into
myofibroblast, thus combining these findings with those of the
Campbell et al. [35]. However, due to the different used
techniques to isolate and describe the cells, it could also be
possible that the cells in the different studies [9,10,13,14] come
from a common origin and only differ by their differentiation
stage.
TGF-b has been shown to induce differentiation of fibrocytes
[13,15]. Autocrine TGF-b stimulation has been hypothesized to
induce spontaneous differentiation of these phenotypes [15] and
seems present in the CD68
+ cell population isolated from
intraperitoneal implants. This hypothesis is supported by the
presence of the TGF-b receptor type II in cultured CD68
+ cells. It
was remarkable that the small round cells in culture showed much
stronger signals than the larger cells, possibly because these larger,
more differentiated cells didn’t need signaling anymore.
Our data suggest the presence of CD34
+ cells, possibly
fibrocytes, within the purified monocyte/macrophage population.
The observed relative augmentation of CD34
+ cells in culture has
already been reported for monocyte-derived fibrocyte-like cells
[36]. These CD34
+ cells actually differentiate into ASMA
+ cells in
culture as demonstrated by the internalized CD34 antigen in
ASMA
+ cells. After 14 days culturing of mononuclear cells only
the fibrocyte population is still present because all other leukocytes
die off [12]. Consequently, the monocyte/macrophage population
from intraperitoneal implants could contain a subpopulation of
fibrocyte-like cells that can survive in culture for at least 3 weeks.
The CD68
+ cells, or at least a subset thereof, are intrinsically
primed to the myofibroblast differentiation pathway and sponta-
neously differentiate without any stimulating supplements, a
property only reported for fibrocytes and probably relying on
autocrine TGF-b stimulation [15]. The CD34
+ cell fraction
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CD68
+CD34
2 cells showed no sign of myofibroblast differentia-
tion, in contrast to the total CD68
+ fraction. All these arguments
suggest the hypothesis that the CD68
+CD34
+ subpopulation
participate in the formation of the mature FBR-population,
consisting mainly of (myo)fibroblasts. Nevertheless this remains to
be confirmed by further studies.
The possibility of transdifferentiation of the total CD68
+ cell
population into ASMA
+ cells is less likely, because no abundant
presence of intermediate stages between monocytes/macrophages
and myofibroblasts could be detected by the CD68/ASMA double
staining. However, further studies are necessary to validate if these
CD34
+ cells actually were fibrocytes, but this was beyond the
scope of this study.
In conclusion, this study shows a switch from monocytes and
macrophages attracted by fibrinogen, to activated macrophages
and eventually wound-healing macrophages. The 3-days imma-
ture FBR-tissue also contains a subpopulation of CD34
+ cells
capable to differentiate into myofibroblasts, the main cell
population in mature FBR-tissue. Further research is necessary
to clarify the effects of the detected signaling molecules on
fibroblasts and define the major source of the mature FBR
myofibroblasts in FBR-tissue.
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